sep 11, 2017 - FDA held a Pediatric Advisory Committee meeting to discuss the use of prescription opioid products containing hydrocodone or codeine for the treatment of cough in pediatric patients. The discussion included current practice for the treatment of cough in children and benefit-risk considerations regarding the use of prescription opioid products in pediatric patients.
Added to timeline:
Date:
sep 11, 2017
Now
~ 8 years and 9 months ago